Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,9012,920 of 20,252 grants

Completed OTHER RESEARCH-RELATED
Immune Regulation of Dormancy at the Metastatic Site
NATIONAL CANCER INSTITUTE State University New York Stony Brook United States 2023 – 2025

PROJECT SUMMARY/ABSTRACT Patients with pancreatic ductal adenocarcinoma (PDAC) and no clinically detectable metastases are treated by surgery. However, >70% of such patients lat...

$491.9K
USD
Active OTHER RESEARCH-RELATED
Role of Gut-Immune Interactions in Aging-Associated Bladder Cancer
NATIONAL CANCER INSTITUTE University of Kansas Medical Center United States 2023 – 2026

ABSTRACT Bladder cancer (BCa) is predominantly a disease of aging with the risk of developing invasive disease peaking in the 8th decade of life. Elderly patients have higher rates...

$1.62M
USD
Completed OTHER RESEARCH-RELATED
Investigating mitochondrial dysfunction in high-risk prostate cancer
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2025

Project Summary/Abstract Prostate cancer incidence in the United States has significantly increased over the last two decades. Despite the improvement of screening strategies, it r...

$1.36M
USD
Active NON-SBIR/STTR RPGS
Psycho-Spiritual Management for Patients with Advanced Cancer and their Family Caregivers
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Given the generally incurable nature of metastatic cancer, patients and their family caregivers are at high risk of experiencing depressive symptoms and sp...

$6.3M
USD
Active SBIR-STTR RPGS
Theranostic for gastric cancer
NATIONAL CANCER INSTITUTE Collagen Medical, Llc United States 2023 – 2026

Project Summary The overarching objective of this application is to develop an image-guided therapy paradigm for improving the management of gastric cancer (GCa) by targeting fibri...

$8.85M
USD
Active NON SBIR/STTR CONTRACTS
Base Title: PREVENT Preclinical Drug Development Program: Preclinical Efficacy and Intermediate Endpoint BiomarkersTask Order Title: Colorectal Cancer (CRC) Prevention by TPST-1495 in PIRC rat mod
NATIONAL CANCER INSTITUTE University of Oklahoma Hlth Sciences Ctr United States 2023 – 2026

The purpose of this Task Order is to evaluate the efficacy and preliminary safety of TPST-1495 for the prevention of Colorectal Cancer (CRC) associated with Familial Adenomatous Po...

$11.4M
USD
Completed SBIR/STTR CONTRACTS
TOPIC 423 (PHASE II): AN INTEGRATED MULTI-LEVEL DECISION SUPPORT PLATFORM TO ADDRESS PATIENT-CENTERED AND EVIDENCE-BASED SOCIAL DETERMINANTS OF HEALTH AMONG CANCER PATIENTS.
NATIONAL CANCER INSTITUTE Pistevo Decision Llc United States 2023 – 2025

A strong body of evidence suggests that addressing Social Determinants of Health (SDH) within healthcare systems advances cancer treatment adherence and reduces disparities in outc...

$20.47M
USD
Active NON-SBIR/STTR RPGS
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
NATIONAL CANCER INSTITUTE Loyola University Chicago United States 2023 – 2028

Project Summary / Abstract This proposal addresses the challenge of closing the racial disparity gap in breast cancer mortality by identifying a contributing biological factor and...

$4.3M
USD
Active OTHER RESEARCH-RELATED
Prognostic Radiomic Signatures in Prostate Cancer Patients on Active Surveillance
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT With prostate cancer (PCa) being among the most common cancers in men worldwide (estimated 1,600,000 cases, 366,000 deaths annually), the need for new biom...

$1.62M
USD
Active NON-SBIR/STTR RPGS
Deep phenotyping of fusion oncoprotein-driven pediatric cancer metastasis with single-cell proteomics
NATIONAL CANCER INSTITUTE Rice University United States 2023 – 2026

SOW/Abstract: The proposed research for the NIH New Innovator Award seeks to biochemically and biophysically characterize complete cytoskeletal phenotypes of metastatic fusion onco...

$13.9M
USD
Completed SBIR-STTR RPGS
Theranostic for gastric cancer
NATIONAL CANCER INSTITUTE Collagen Medical, Llc United States 2023 – 2024

Project Summary The overarching objective of this application is to develop an image-guided therapy paradigm for improving the management of gastric cancer (GCa) by targeting fibri...

$3.96M
USD
Active OTHER RESEARCH-RELATED
R25 YES: Cancer Research Opportunities at Iowa
NATIONAL CANCER INSTITUTE University of Iowa United States 2023 – 2028

Houtman/Lubaroff Summary/Abstract Underrepresented (UR) populations are less likely to obtain advanced degrees in the field of cancer research. In an attempt to address this proble...

$2.75M
USD
Active NON-SBIR/STTR RPGS
Attacking the Immunopeptidome of Ewing Sarcoma
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

PROJECT SUMMARY Solid cancers are a leading cause of cancer related death in children and there is great interest in harnessing recent progress in immunotherapy for the treatment o...

$4.67M
USD
Active OTHER RESEARCH-RELATED
Prognostic Radiomic Signatures in Prostate Cancer Patients on Active Surveillance
NATIONAL CANCER INSTITUTE Washington University United States 2023 – 2026

PROJECT SUMMARY/ABSTRACT With prostate cancer (PCa) being among the most common cancers in men worldwide (estimated 1,600,000 cases, 366,000 deaths annually), the need for new biom...

$1.61M
USD
Active NON-SBIR/STTR RPGS
Psycho-Spiritual Management for Patients with Advanced Cancer and their Family Caregivers
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2023 – 2028

PROJECT SUMMARY/ABSTRACT Given the generally incurable nature of metastatic cancer, patients and their family caregivers are at high risk of experiencing depressive symptoms and sp...

$6.94M
USD
Active NON-SBIR/STTR RPGS
SELENOF is a Novel Tumor Suppressor and a New Target to Overcome Racial Disparity in Breast Cancer.
NATIONAL CANCER INSTITUTE Loyola University Chicago United States 2023 – 2028

Project Summary / Abstract This proposal addresses the challenge of closing the racial disparity gap in breast cancer mortality by identifying a contributing biological factor and...

$4.66M
USD
Completed SBIR/STTR CONTRACTS
Topic 447: Development and testing of a non-invasive cryo-device to prevent chemotherapy-induced peripheral neuropathy in hands and feet of cancer patients receiving Taxol for breast cancer.
NATIONAL CANCER INSTITUTE Eisana Corp United States 2023 – 2024

The objective of this proposal is to develop a prototype device capable of cooling extremities to a level sufficient for prevention of chemotherapy-induced peripheral neuropathy (C...

$4M
USD
Active NON-SBIR/STTR RPGS
CD 1530, an RAR Gamma Agonist for Oral Cavity Squamous Cell Carcinoma Prevention
NATIONAL CANCER INSTITUTE Weill Medical Coll of Cornell Univ United States 2023 – 2028

Abstract Despite intensive treatments that often combine surgery, chemotherapy, and radiation, patients with head and neck squamous cell carcinomas (HNSCCs), including oral cavity...

$4.34M
USD
Active OTHER RESEARCH-RELATED
R25 YES: Cancer Research Opportunities at Iowa
NATIONAL CANCER INSTITUTE University of Iowa United States 2023 – 2028

Houtman/Lubaroff Summary/Abstract Underrepresented (UR) populations are less likely to obtain advanced degrees in the field of cancer research. In an attempt to address this proble...

$3.73M
USD
Active NON-SBIR/STTR RPGS
Attacking the Immunopeptidome of Ewing Sarcoma
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

PROJECT SUMMARY Solid cancers are a leading cause of cancer related death in children and there is great interest in harnessing recent progress in immunotherapy for the treatment o...

$6.63M
USD